NL-OMON47365已完成不适用
In vitro Screening of drug candidates against cancer and autoimmune diseases for effects on human blood cells - In vitro screening of new drug candidates
Farmacologie0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •aged 18-65 years
排除标准
- •Not healthy
- •Use of prescription drugs up to 1 week before blood draw
研究者
相似试验
招募中
Unknown
Autologous Vax-NK/HCC Consolidation Therapy in Patients with Extensive Stage Small Cell Lung CancerNeoplasmsKCT0008301Chonnam National University Hospital Hwasun Hospital12
进行中（未招募）
1 期
Selinexor in the treatment of patients with Refractory and/or Relapsed Richter's TransformatioEUCTR2014-001240-38-GBKaryopharm Therapeutics Inc.50
进行中（未招募）
1 期
Richters TransformatioInitial and Refractory/Relapsed Richters Transformation (RT)MedDRA version: 18.0Level: PTClassification code 10058728Term: Richter's syndromeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001240-38-DEKaryopharm Therapeutics, Inc.50
进行中（未招募）
1 期
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination StudyCarcinoma, Non-Small-Cell LungNCT03381274MedImmune LLC43
进行中（未招募）
1 期
Predictive value of analyzing cancer cells from patients with pancreatic cancer for possible effect of different anti-cancer drugsMedDRA version: 20.0 Level: LLT Classification code 10033605 Term: Pancreatic cancer metastatic System Organ Class: 100000004864MedDRA version: 20.0 Level: LLT Classification code 10033606 Term: Pancreatic cancer non-resectable System Organ Class: 100000004864EUCTR2018-003112-53-DKVejle Hospital30